Advertisement
Advertisement

SLP

SLP logo

Simulations Plus Inc.

34.14
USD
+0.34
+1.01%
Jan 30, 15:58 UTC -5
Closed
...

Simulations Plus Inc. Profile

About

Simulations Plus, Inc., is a premier developer of groundbreaking drug discovery and development simulation software, which is licensed to and used in the conduct of drug research by major pharmaceutical and biotechnology companies worldwide. They have two other businesses, Words+, Inc. and FutureLab, which are based on its proprietary software technologies.

Info & Links

CEO

Shawn O¿Connor

Headquarters

42505 10TH STREET WEST
LANCASTER, CA 93534, UNITED STATES

Auditor

Rose, Snyder & Jacobs LLP

Share holders

37

Employees

247

Simulations Plus Inc. Statistics

Valuation Measures

Market Capitalization2

685.19M

Enterprise Value

679.00M

Enterprise Value/EBITDA(ttm)

59.69

Price to Earnings Ratio(ttm)

53.13

Price to Sales(ttm)

8.89

Price to Book(mrq)

3.58

Price to Cash(ytd)

42.94

Profitability

Gross Margin(ttm)

58.57%

Operating Margin(ttm)

16.67%

Profit Margin(ttm)

11.13%

Return on Equity(ttm)

6.84%

Return on Invested Capital(ttm)

4.58%

Return on Assets(ttm)

6.34%

Income Statement

Revenue(ttm)

74.44M

Revenue Per Share(ttm)

3.70

Gross Profit(ttm)

43.52M

EBITDA(ttm)3

11.38M

Net Income Available to Common(ttm)

8.21M

Diluted EPS(ttm)

0.40

Share Statistics

Beta (5Y Monthly)

0.80

52-Week Change

-11.67%

S&P 500 52-Week Change

25.29%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

20.09M

Dividend Yield

0.00%

Float4

16.19M

% Held by Insiders

19.40%

% Held by Institutions

78.08%

Balance Sheet

Total Cash(mrq)

18.17M

Total Cash Per Share(mrq)

0.90

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

4.15%

Quick Ratio(mrq)

4.15%

Book Value Per Share(mrq)

9.20

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.06

Free Cash Flow(ytd)

-2.00M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement